Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of JNJ-64565111 in non-diabetic severely obese participants has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• JNJ-64565111

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05